Stem Cells May Help Pinpoint Patient-Specific Painkiller (IMAGE)

American Association for the Advancement of Science (AAAS)

Stem Cells May Help Pinpoint Patient-Specific Painkiller

Caption

Induced pluripotent stem cells (iPSCs) from inherited erythromelalgia (IEM) subjects and non-IEM donors differentiating into sensory neurons. This material relates to a paper that appeared in the April 20, 2016 issue of Science Translational Medicine, published by AAAS. The paper, by L. Cao at Pfizer Neuroscience and Pain Research Unit in Cambridge, U.K., and colleagues was titled, "Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia."

Credit

Cao <i>et al., Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.